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Dysregulation of the inflammatory responses has been suggested to contribute to the
events leading to sudden infant deaths. Our objectives were (1) to analyze a single
nucleotide polymorphism (SNP) associated with high levels of tumor necrosis factor-
α (TNF-α) responses, TNF G-308A, in sudden infant death syndrome (SIDS) infants,
SIDS and control parents, and ethnic groups with different incidences of SIDS; (2)
the effects of two risk factors for SIDS, cigarette smoke and virus infection, on TNF-
α responses; and (3) to assess effects of genotype, cigarette smoke, and gender on
TNF-α responses to bacterial toxins identified in SIDS infants. TNF G-308A genotypes
were determined by real-time polymerase chain reaction for SIDS infants from Australia,
Germany, and Hungary; parents of SIDS infants and their controls; and populations with
high (Aboriginal Australian), medium (Caucasian), and low (Bangladeshi) SIDS incidences.
Leukocytes from Caucasian donors were stimulated in vitro with endotoxin or toxic
shock syndrome toxin-1 (TSST-1). TNF-α responses were measured by L929 bioassay
(IU/ml) and assessed in relation to genotype, smoking status, and gender. There was
a significantly higher proportion of the minor allele AA genotype among Australian SIDS
infants (6/24, 24%) compared to 3/62 (4.8%) controls (p=0.03). There were no significant
differences in TNF-α responses by TNF G-308A genotypes when assessed in relation
to smoking status or gender. Given the rarity of the TNF G-308A A allele in Caucasian
populations, the finding that 24% of the Australian SIDS infants tested had this genotype
requires further investigation and cautious interpretation. Although non-smokers with the
AA genotype had higher TNFα responses to both TSST-1 and endotoxin, there were too
few subjects with this rare allele to obtain statistically valid results. No effects of genotype,
smoking, or gender were observed for TNF-α responses to these toxins.
Keywords: sudden infant death syndrome, TNF-α , ethnicity, cigarette smoke
Introduction
Tumor necrosis factor-α (TNF-α) is a key pro-inflammatory cytokine which could play a role in
several of the mechanisms proposed to explain sudden infant death syndrome (SIDS). In relation
to the anaphylaxis hypothesis, TNF-α is stored in mast cell granules and is released on antigen
stimulation. TNF-α also induces fever and affects respiration (1) and can affect myocardial function
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(2, 3). One of its single nucleotide polymorphisms (SNPs), TNF
G-308A, has been associated with severe responses to infection.
Cytokine gene polymorphisms can significantly affect the level of
these substances produced in response to infection (4). In vitro
studies found that the A allele was associated with increased
responses (5) and individuals homozygous for the A allele had
higher levels of circulating TNF-α (6). The molecular basis for
the A allele being a more powerful transcriptional activator is
not clear; however, the region  323 to  285 has been found to
bind nuclear factors differently compared with the corresponding
G allele (7).
Reports on the TNF G-308A SNP indicate the AA genotype
carried an increased risk of death from cerebral malaria (8), septic
shock (9), and death frommeningococcal sepsis (10). Two studies
examined SNPs for TNF-α among Scandinavian SIDS infants
and found no significant association (11, 12). Because of the
variability of reports on findings for a variety of SNPs among
SIDS infants in different populations, we examined the TNF G-
308A genotypes among material from our collection of samples
from Germany, Hungary, and Australia. Because of the variation
in the incidence of SIDS among different ethnic groups, we also
included comparison groups from populations with low (South
Asian), moderate (Caucasian), or high (Indigenous Australian)
incidences of SIDS.
Although gene polymorphisms are important determinants
of the cytokine responses, we have reported that three major
risk factors associated with SIDS – gender, exposure to cigarette
smoke, and virus infections – can significantly influence these
responses (13–15). In this study, we used model systems to assess
interactions between these risk factors and TNF-α responses
elicited by components of bacterial species identified in SIDS
infants, lipopolysaccharide (LPS) of Gram-negative species (16,
17), and toxic shock syndrome toxin-1 (TSST-1) of Staphylococcus
aureus (18).
The objectives of the study were (1) to analyze the distribu-
tion of TNF G-308A alleles among SIDS infants, SIDS parents,
an unrelated adult comparison group, and ethnic groups with
different incidences of SIDS; (2) to assess effects of virus infection
and cigarette smoke on TNF-α responses; and (3) to assess the
effect of gender, TNF G-308A, and cigarette smoke on responses
to bacterial antigens (LPS and TSST-1) identified in SIDS infants.
Subjects and Methods
Approval for the study was obtained from the Lothian Health
Ethics Committee (UK), Hunter Area Research Ethics Committee
(Australia) and the University of Newcastle Human Research
Ethics Committee (Australia).
Assessment of TNF G-308A SNP
Buccal epithelial cells were collected from Caucasian parents of
SIDS infants from Britain (n= 34) and Australia (n= 60) and
a comparison group with no family history of sudden infant
deaths (Britain n= 56, Australia n= 62). Paraffin-fixed samples
of tissue from SIDS infants were obtained fromAustralia (n= 25),
Hungary (n= 18), and Germany (n= 46). Stored frozen blood
samples fromAboriginal Australians (n= 117) and buccal epithe-
lial cells from Bangladeshi donors (n= 32) were used as sources
of DNA for comparisons among ethnic groups. The methods
for extraction of DNA from the samples have been described
previously (13).
TNF G-308A (rs1800629) genotype was determined by a com-
mercial allelic discrimination polymerase chain reaction (PCR)
assay (Assay ID: C___7514879_10) (PE Applied Biosystems).
Primers and probes were provided in a 20 assay mix, sequences
and concentrations of which are unknown.
Each PCR reaction contained 10 ng of sample DNA, 1 Assay
mix, and 1 TaqMan Universal PCR Master Mix (PE Applied
Biosystems) made up to a final volume of 5µl with sterilized
MilliQ water. PCR was performed using the ABI PRISM 7900HT
sequence detection system (PE Applied Biosystems) at the follow-
ing thermal cycling conditions: 50°C for 2min; 95°C for 10min;
92°C for 15 s; and 60°C for 1min, for 40 cycles.
Data were analyzed using the statistical software package
Statistics/Data Analysis™ (STATA) Version 8.0 (Stata Corpo-
ration, College Station, USA). The Chi-square (χ2) test or
Fisher’s Exact test, if appropriate, was used to assess the dis-
tribution of TNF G-308A in SIDS infants, parents of SIDS
infants, and between ethnic groups. Genotype distribution from
the Hardy–Weinberg equilibrium (HWE) was assessed using the
χ
2 test.
Assessment of the Effects of Interferon-γ (IFN-γ)
and Cigarette Smoke Extract (CSE) on TNF-α
Responses Elicited by Endotoxin from THP-1
Cells
Tumor necrosis factor-α responses of the THP-1 human mono-
cytic cell line were measured as previously described in the
model system to assess the effects of surrogates for infection
(IFN-γ) and exposure to CSE on cells with a uniform genetic
background (19).
Assessment of the Effects of IFN-γ and CSE on
TNF-α Responses from Human Peripheral Blood
Monocytic Cells
Collection, isolation, and storage of human peripheral blood
monocytic cells (PBMC) have been described previously. Buffy
coats from 14 male and 14 female donors, aged 20–55 years, were
purchased from the Australian red cross blood service (ARCBS)
(Sydney, Australia). Ethical permission was obtained from Uni-
versity of Newcastle Human Research Ethics Committee (H-
229–0606) and ARCBS Ethics Committee (07-11NSW-07) for
the purchase and use of human buffy coats for the purposes of
the study. PBMC were collected from each donor for in vitro
cytokine stimulation assays and plasma was collected for the
assessment of cotinine for evidence of exposure to cigarette smoke,
a confounding variable for altered cytokine responses. TNF G-
308A genotype was determined as described above. Donors with
detectable levels of cotinine were excluded from the analysis. Only
ARCBS donor samples that were cleared for infectious agents
were received. Leukocytes were collected and stored as described
previously (15).
In our initial studies, TNF-α responses were examined with
blood samples (10–20ml) collected from British parents of SIDS
infants (n= 34) and a comparison group, individuals unrelated
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to the families and who had no family history of SIDS (n= 59).
DNA was extracted from the leukocytes and screened for the
TNF G-308A alleles as described above. The leukocytes were
assessed for inflammatory responses to TSST-1 and LPS as
described previously. All samples were coded and tested without
knowing the sex or smoking status of the donors. Leukocytes
(1 106 cellsml 1) were stimulated in vitro with 0.01µgml 1
or 1µgml 1 Escherichia coli LPS or 0.5µgml 1 TSST-1 (Sigma,
Poole, Dorset, UK) for 24 h. Cell culture conditions have been
described previously (13).
Quantitative Assessment of TNF-α
Production of biologically active TNF-α was assessed by bioassay
with L929 cells as described previously. The results were expressed
as international units derived from the standard curves obtained
using a recombinant human TNF-α standard.
Statistical Methods
Student’s t-test was used on log10 -transformed data to assess
differences in TNF-α responses for the various experimental
conditions tested. The significance level for all tests was set at
p< 0.05.
Results
The distributions of genotypes among the different groups
assessed are summarized in Table 1. Distributions were in HWE
for each of the groups assessed.
Distribution of TNF G-308A among SIDS Infants
The majority of each SIDS group possessed the GG genotype;
however, Australian SIDS infants had a significant increase in pro-
portion with the AA genotype (6/25, 24%) compared to the Hun-
garian (0/18, 0%) (p= 0.09) and German (0/46, 0%) (p< 0.01)
SIDS infants.
The distribution of allele frequencies for the Australian control
populationdiffered significantly from that observed forAustralian
SIDS infants (p= 0.02). Only 3/62 (5%) of controls had the AA
genotype compared with 24% of SIDS infants. No significant
differences were detected between the distribution of TNF G-
308A genotype for the combined SIDS infant group compared to
the Caucasian controls (p= 0.41).
Assessment of TNF G-308A among Parents of
SIDS Infants
The distribution of TNF G-308A genotype among parents of
SIDS infants was not significantly different compared with their
respective control populations. Parents of SIDS infants recruited
from Australia showed an increased proportion of individuals
with the GA genotype compared to their matched Australian
controls but this was not significant (p= 0.22). Parents of SIDS
infants recruited from Britain had a genotype distribution similar
to their control population; themajority of individuals had theGA
genotype (p= 0.89).
Distribution of TNF G-308A in Different
Ethnic Groups
The distribution of TNF G-308A varied significantly among indi-
viduals from different ethnic groups. The majority of both British
and Australian control populations possessed the GG genotype
with fewer than 5% of individuals possessing the AA genotype.
As there were no differences between the allele frequencies
for British and Australian control populations, these data were
combined for further comparison with the Bangladeshi and Abo-
riginal Australian populations. The distribution of allele frequen-
cies differed significantly between the Caucasian group and both
Bangladeshis (p= 0.01) and Aboriginal Australians (p< 0.01).
More than 90% of the Bangladeshi and Aboriginal Australian
populations possessed the GG genotype, and 0% had the AA
genotype.
TABLE 1 | TNF G-308A allele frequency distribution in the study populations.
Ethnicity Group Allele frequency (%) Sample size (n) p value (p)
GG GA AA
British SIDS Parents 65 35 0 34 0.89
British Control Parents 66 32 2 56
Australian SIDS Parents 57 40 3 60 0.22
Australian Control Parents 69 26 5 62
Australian SIDS Infants 48 28 24 25 0.03a
Hungarian SIDS Infants 61 39 0 18 0.05b 0.09c
German SIDS Infants 85 15 0 46 <0.01d
Combined SIDS Infants 70 24 7 89 0.41e
Bangladeshi Control 94 6 0 32 0.01f
Aboriginal Australian Control 99 1 0 117 <0.01g 0.12h
Caucasian Control 68 29 3 118
aAustralian SIDS infants vs. Australian control parents.
bHungarian SIDS infants vs. German SIDS infants.
cHungarian SIDS infants vs. Australian SIDS infants.
dGerman SIDS infants vs. Australian SIDS infants.
eCombined SIDS infants vs. Caucasian control.
fBangladeshi control vs. Caucasian control.
gAboriginal Australian control vs. Caucasian control.
hAboriginal Australian control vs. Bangladeshi control.
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Effects of INF-γ and CSE on TNF-α Responses of
THP-1 Cells to LPS
Unstimulated THP-1 cells had no measurable TNF-α in response
to INF-γ at 1 ngml 1 (low) or 10 ngml 1 (high) concentra-
tions. Priming of THP-1 cells with INF-γ resulted in dose-
dependent enhancement of TNF-α responses to LPS (50 ngml 1)
(Figure 1A). Neither low (L) (0.0001 cigarette per milliliter) nor
high (H) (0.001 cigarette per milliliter) concentrations of CSE
elicitedmeasurable TNF-α. There was a dose-dependent but non-
significant reduction in TNF-α responses to LPS in the presence
of low dose of CSE (Figure 1B). In the presence of the high dose
of CSE and either high or low concentrations of IFN-γ, TNF-
α responses were significantly enhanced compared to stimula-
tion with LPS alone (Figure 1C). The IFN-γ-enhanced TNF-α
responses were not reduced by the CSE exposure.
Effects of INF-γ and CSE on TNF-α Responses of
Human PBMC to LPS
Peripheral blood monocytic cells from 28 blood donors who had
no evidence of cigarette smoke exposure or infectionwere used for
assessment of the effects of CSE and INF-γ on TNF-α responses
to LPS in relation to genotype. Baseline levels of TNF-α responses
elicited by the individual components and combinations of com-
ponents were approximately twice those elicited from THP-1
cells (Figure 2A). INF-γ priming significantly enhanced TNF-α
responses (p< 0.0001). As observedwith THP-1 cells, CSE did not
elicit TNF-α from PBMC. In contrast to the results obtained with
THP-1 cells, the high dose of CSE significantly reduced TNF-α
responses to LPS (p< 0.0001) (Figure 2B). The presence of both
INF-γ and CSE resulted in enhanced TNF-α responses compared
with LPS alone; however, the response was lower if pre-treated
with CSE and INF-γ than if pre-treated treated with INF-γ alone
(p< 0.0001). (Figure 2C).
When assessed by gender of the donor, therewere no significant
differences between: TNF-α responses to LPS, INF-γ, or CSE; or
combinations of LPS with CSE or LPS with INF-γ. There was a
significant difference in TNF-α responses of cells from female
donors (6510 pgml 1) compared with responses from cells of
male donors (4621 pgml 1) if both INF-γ and CSE were used to
pre-treat cells prior to exposure to endotoxin (p= 0.014). There
were no significant differences in TNF-α responses associated
with genotypes GG (n= 15), GA (n= 10) or AA (n= 3) under
any of the conditions tested. For donors with the GG geno-
type, there were higher responses to LPS from cells of female
donors (n= 9) (1674 pgml 1) than from cells of male donors
(n= 6) (989 pgml 1) (p= 0.03). While the responses from cells
of females with theGA genotype (n= 2) were approximately twice
that of those fromcells ofmale donors (n= 8), the differenceswere
not significant (p> 0.05). There were only three donors with the
AA genotype and all were female.
Effect of Smoking, Gender, and TNF G-308A on
TNF-α Responses to LPS or TSST-1
This experiment utilized cells from the UK donors. There were no
significant differences in the median TNF-α response to TSST-1
or LPS associated with different genotypes of TNF G-308A for
smokers (n= 38) or non-smokers (n= 60). For the GG and GA
FIGURE 1 | Effects of IFN-γ and CSE on TNF-α responses of THP-1
cells to LPS (50ngml 1). (A) TNF-α responses of THP-1 cells to LPS
(50 ngml 1) and IFN-γ at 1 ngml 1 (IFN 1) or 10 ngml 1 (IFN 10) (*p<0.05).
(B) TNF-α responses of THP-1 cells to LPS (50 ngml 1) and CSE at low level
(CSE L= 0.0001 cigml 1) and high level (CSE H= 0.001 cigml 1).
(C) TNF-α responses of THP-1 cell to LPS (50 ngml 1) and CSE
(0.001 cigml 1) and IFN-γ at low level (IFN L= 1 ngml 1) and high level (IFN
H= 10 ngml 1) (*p<0.05).
genotypes, the geometric mean TNF-α responses were below
10 IUml 1. For the three donors with the AA genotype, there was
one smoker and two non-smokers. The responses of the smoker
donor with the AA genotype were similar to those of the GG
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FIGURE 2 | Effects of IFN-γ and CSE on TNF-α responses of PBMC to
LPS (50ngml 1). (A) Effect of IFN-γ (10 ngml 1) pre-treatment on LPS
stimulation of TNF-α from PBMC (n= 28) (***=p<0.0001). (B) The effect of
CSE (0.001 cigml 1) pre-treatment on LPS (50 ngml 1) stimulation of TNF-α
from PBMC (n= 28) (***=p<0.0001). (C) The effect of CSE (0.001 cigml 1)
and IFN-γ (10 ngml 1) pre-treatment on LPS stimulation of TNF-α from
PBMC (n= 28) (***=p<0.0001).
and GA donors (<10 IUml 1). The response of the two donors
who were not smokers was nearly 20 IUml 1 for responses to
TSST-1 and over 50 IUml 1 for responses to the higher dose of
LPS. There were not enough donors with the AA genotype for
statistical analyses.
Discussion
In this study, we found an association with the TNF G-308A
genotype AA in Australian SIDS infants. Given the rarity of the
TNF G-308A A allele in the Caucasian population, it was an
unusual observation that 24%of theAustralian SIDS infants tested
in this study were homozygous. The number of infants assessed
in this study was small; therefore, data should be interpreted
with caution. In the Norwegian study, 3% of SIDS infants, 5%
of borderline SIDS, and 3% of infants who died of infection
had the AA genotype; while none of the controls had this SNP
genotype (11).
While the distribution of TNF G-308A genotype in the Indige-
nous Australian population differed significantly from that in the
Caucasian population, the groups with high (Indigenous Aus-
tralian) or low (UK Bangladeshi) incidences of SIDS had similar
genetic profiles.
If the finding of a significant increase in the AA genotype
associated with high TNF-α reflects a risk factor for SIDS, the
findings need to be assessed in relation to the various hypotheses
proposed to explain the physiological events leading to SIDS.
Long QT interval is reported to be an important risk factor
for SIDS based on a prospective study of a large group of infants
(20). The resident myocardial macrophages and mast cells and
cardiomyocytes synthesize TNF-α. Arrhythmia has been reported
as a side effect of treatment of patients with metastatic cancer
with TNF-α, IL-2, and IFN-γ (21, 22). Negative ionotropic and
arrhythmogenic effects were observed in myocytes cultured in
IL-1, IL-2, IL-3, and TNF-α (23).
Dysregulation of glucose metabolism was proposed as one
mechanism triggering the physiological events leading to SIDS
(24). Acute hypoglycemia was associated with deranged cytokine
levels. Hypoglycemia induced in rats with TNF-αwithout changes
in the insulin levels was ameliorated by corticosteroid therapy
(25). Hypoglycemia in an elderly patient with non-Hodgkin’s
lymphoma was associated with normal insulin and insulin-
like hormone levels but high TNF-α levels. Glucose home-
ostasis was normalized after lowering TNF-α by cytoreductive
therapy (26).
The A allele has been associated with increased production
of TNF-α (27, 28). The cytokine response, however, is multi-
redundant and pleiotropic; therefore, inactivation or over produc-
tion of a particular cytokine might not have an effect on its own.
When combined with other imbalances in the cytokine cascade,
real physiological differences could be observed. It is, therefore,
important to interpret cytokine and cytokine SNP data with cau-
tion and to consider the effects of other genetic, developmental,
and environmental influences on these responses.
Despite finding interactions with smoking and cytokine gene
polymorphisms in our previous studies (13), this study found
no significant effects of gender, active smoking, or TNF G-308A
genotype on TNF-α responses to TSST-1 or LPS in the different
populations. Although the responses of the non-smokers with
the AA genotype were higher than those observed for the other
genotypes, there were too few donors with this genotype for
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statistical analyses. These studies need to be repeated with more
samples from individuals with the rare genotype.
In the experiments with cells from healthy Australian blood
donors which were controlled for exposure to cigarette smoke
and infection, females generally had higher TNF-α responses
than males (15). When assessed by gender, females with the AA
genotype had the lowest responses to the different conditions
tested. This is in contrast to the results with cells from UK donors
in which the rare AA genotype had the highest TNF-α responses
to either TSST-1 or LPS. There are several factors that could
contribute to the differences. In the study with Australian donors,
TNF-α was assessed by Bio-Rad 6-plex assays and the Luminex
200 analyzer; this method detects total TNF-α. TNF-α responses
from cells of the UK donors were tested for cytotoxicity for the
L929 cell line which measures the biologically active TNF-α.
The numbers of Australian donors tested were also smaller than
those in the UK study. The UK samples were not assessed for
level of exposure to cigarette smoke or concurrent viral infec-
tions which we have demonstrated can significantly alter cytokine
responses including TNF-α. For the donors in the UK study,
exposure to cigarette smoke was assessed only by self-reported
smoking.
In conclusion, the TNF G-308A genotype results indicated that
for the Australian population, infants with the AA genotypemight
be at increased risk of SIDS. The study needs to be expanded
and investigations need to include thorough investigation for
microorganisms and their toxins as well as investigation of the
genetics and cytokine responses. While the effects of genotype
on TNF-α responses remain unclear in the models tested, the
effects of INF-γ are unequivocal for both THP-1 cells and PBMC.
The results indicate that virus infection might enhance TNF-α
responses tominor bacterial infection.While exposure to cigarette
smoke is a risk factor for SIDS, it does not appear to enhance
TNF-α responses to LPS. For the PBMC studies, CSE reduced
significantly the enhanced responses of IFN-γ primed cells to LPS.
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